US loss of exclusivity · Cardiometabolic
Eliquis
Bristol Myers Squibb / Pfizer
2028
US generics from
2025
Today: 2026
2037
2025 worldwide sales
$14.4B
Date basis
Settlement / court date
US generics
Approved, waiting to launch
Medicare price
−56% from 2026
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Eliquis timeline →